Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "expectorant effect on respiratory tract" refers to the capacity of a substance, typically a medication, to promote the expulsion of mucus from the airways, bronchi, and lungs. This effect is mediated by various mechanisms, such as increasing the water content of mucus to make it less viscous, stimulating respiratory fluid secretion, or acting reflexively via the vagal pathway to recruit secretion of less viscous mucus. Common medicinal agents that elicit an expectorant effect include guaifenesin, bromhexine, ambroxol, hypertonic saline, and various herbal preparations. This term is not a molecular target and does not designate a specific biochemical receptor, enzyme, channel, or protein.
Increases the water content of mucus, reducing viscosity. Stimulates respiratory tract fluid secretion. Irritates gastric vagal receptors to induce glandular exocytosis in the airways. Facilitates mucociliary clearance or productive cough.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Expectorant effect on respiratory tract.